european
viru
archiv
eva
creat
fund
infrastructur
programm
respons
need
coordin
readili
access
collect
virus
could
made
avail
academia
public
health
organis
industri
gould
et
al
within
three
year
develop
consortium
nine
european
laboratori
encompass
associ
partner
africa
russia
china
turkey
germani
itali
follow
call
research
innov
framework
programm
infra
project
concept
develop
eva
global
organ
natur
progress
project
fund
fouryear
period
april
evag
start
oper
nonprofit
consortium
includ
partner
associ
partner
eu
noneu
countri
base
excel
progress
first
two
oper
year
everi
reason
believ
consortium
continu
expand
ultim
constitut
world
largest
viru
collect
paper
outlin
structur
manag
goal
evag
bring
attent
research
wealth
product
provid
illustr
endus
gain
access
resourc
laboratori
isol
characteris
viral
pathogen
vaccinia
viru
polioviru
foot
mouth
diseas
viru
yellow
fever
viru
other
began
turn
twentieth
centuri
repres
pioneer
era
develop
medic
veterinari
virolog
year
diagnost
research
centr
establish
worldwid
investig
virus
caus
wide
rang
diseas
includ
hitherto
escap
attempt
identifi
cultur
laboratori
condit
centuri
evergrow
number
mammalian
virus
continu
isol
may
repres
tip
iceberg
virus
discov
report
use
rapidli
develop
molecular
technolog
result
advanc
isol
identif
characteris
preserv
grow
viru
collect
inevit
gener
new
challeng
mani
known
virus
collect
may
lost
discard
virologist
charg
retir
laboratori
close
reorgan
collect
may
avail
wider
virolog
commun
scientist
alway
will
posit
share
viral
isol
may
lack
infrastructur
time
manpow
facil
experi
character
present
collect
access
catalogu
abl
ship
collect
strain
foreign
countri
due
restraint
impos
increasingli
complex
transport
regul
furthermor
mani
govern
introduc
addit
secur
measur
specif
regul
transfer
andor
exchang
countri
highriskgroup
pathogen
may
attract
interest
terrorist
organis
addit
laboratori
russia
china
india
southeast
asia
south
america
hold
viru
collect
mani
date
rel
inaccess
european
laboratori
virus
mani
taxonom
famili
also
identifi
african
contin
welldevelop
laboratori
africa
made
collect
readili
access
research
europ
america
current
howev
except
countri
includ
seneg
south
africa
kenya
authent
viru
collect
region
africa
virtual
nonexist
one
object
evag
therefor
establish
trust
among
wide
dispar
institut
associ
scientist
countri
partner
consortium
care
monitor
condit
protect
develop
laboratori
mutual
benefit
everyon
current
project
aim
develop
viru
collect
lowincom
countri
case
understand
reluct
exchang
virus
fear
lose
resourc
institut
highli
develop
countri
evag
infrastructur
provid
assur
access
modern
capac
therebi
assist
institut
train
staff
develop
resourc
expand
maintain
capac
local
endus
request
virus
reagent
develop
laboratori
entir
manag
within
support
qualiti
manag
distribut
system
consortium
common
member
consortium
develop
laboratori
automat
retain
full
ownership
collect
elsewher
research
laboratori
often
accumul
collect
virus
primarili
depend
special
laboratori
scientist
exampl
american
type
cultur
collect
atcc
us
centr
diseas
control
prevent
cdc
maintain
larg
collect
mammalian
viral
pathogen
includ
risk
group
agent
laboratori
russia
china
india
southeast
asia
south
africa
australia
new
zealand
hold
collect
isol
specif
countri
rel
larg
collect
arbovirus
current
held
usa
galveston
nation
laboratori
texa
franc
czech
republ
slovakia
also
countri
scandinavia
european
collect
specifi
anim
pathogen
particularli
lyssavirus
pestivirus
arbovirus
influenza
virus
maintain
anim
plant
health
agenc
pirbright
institut
unit
kingdom
itali
istituto
zooprofilattico
sperimental
dell
venezi
izsv
host
world
organ
anim
healthfood
agricultur
organ
oiefao
eu
refer
laboratori
avian
influenza
franc
institut
pasteur
virus
ebola
nipah
maintain
specialis
facil
franc
germani
russia
usa
china
south
africa
uk
divers
virus
medic
veterinari
import
coronavirus
herpesvirus
retrovirus
adenovirus
enterovirus
etc
held
laboratori
around
world
evag
continu
develop
expand
boundari
access
greater
proport
virus
enabl
possibl
recent
meet
challeng
emerg
virus
consortium
voluntarili
orient
part
activ
support
world
health
organ
emerg
health
crise
dedic
new
workpackag
entitl
respons
emerg
moreov
evag
current
associ
partner
global
outbreak
alert
respons
network
goarn
current
process
coordin
viru
standardis
characteris
preserv
distribut
inevit
rel
arbitrari
larg
depend
special
laboratori
fact
besid
evag
unawar
nonprofit
organ
concern
facilit
reliabl
access
global
virus
associ
reagent
individu
viru
collect
research
andor
diagnost
laboratori
teach
centr
industri
involv
product
diagnost
reagent
pharmaceut
vaccin
sole
benefit
scienc
safe
care
regul
manner
would
virtual
imposs
establish
singl
laboratori
maintain
suppli
recognis
pathogen
mammalian
virus
base
knowledg
experi
gain
former
eva
project
address
problem
use
webbas
tool
centralis
access
qualitycontrol
standardis
prepar
virus
held
laboratori
worldwid
underli
concept
simpl
virologist
natur
protect
collect
success
requir
paradigm
shift
mindset
partner
associ
partner
individu
laboratori
framework
programm
european
union
eu
place
call
fund
applic
head
research
innov
action
subhead
one
research
infrastructur
accordingli
concept
evag
creat
fund
propos
submit
prepar
propos
emphasis
would
virtual
imposs
gener
widerang
viru
archiv
singl
laboratori
complex
thu
although
mani
highcalibr
virolog
laboratori
oper
europ
decid
retain
virolog
club
tradit
develop
principl
integr
intern
infrastructur
via
consortia
oper
valid
network
far
awar
concept
previous
encompass
virologist
context
produc
provid
access
virus
evag
therefor
conceiv
fill
gap
access
virus
identif
qualifi
intern
laboratori
could
becom
partner
consortium
agre
integr
collect
resourc
devis
appropri
valid
protocol
effect
dissemin
procedur
partner
laboratori
would
abl
achiev
common
high
standard
produc
suppli
authent
virus
scientif
commun
within
outsid
europ
evag
uniqu
conceiv
move
beyond
current
state
art
provid
access
largest
collect
mammalian
virus
associ
reagent
world
global
scientif
commun
govern
health
environment
depart
higher
educ
institut
industri
appropri
inform
system
new
approach
first
instanc
integr
noneu
partner
beneficiari
project
possibl
rule
reciproc
benefit
agre
noneu
partner
provis
activ
materi
eu
entiti
research
institut
health
organ
anim
healthcar
structur
etc
elig
financi
compens
consortium
eu
budget
consequ
highcalibr
european
noneuropean
partner
laboratori
agre
becom
primari
member
evag
consortium
list
tabl
partner
laboratori
form
core
evag
list
chronolog
order
integr
project
medic
veterinarian
institut
includ
cover
viral
zoonot
diseas
also
illustr
wide
geograph
coverag
alreadi
attain
demonstr
laboratori
major
contributor
consortium
choic
institut
also
reflect
specif
avail
skill
knowhow
scientist
institut
close
associ
wellknown
contemporari
emerg
virus
also
begun
integr
network
organis
global
approach
biolog
research
infecti
diseas
epidem
lowincom
countri
gabriel
network
fondat
merieux
intern
pasteur
institut
futur
plan
includ
expans
partnership
countri
current
repres
malaysia
vietnam
cambodia
indonesia
south
america
addit
african
countri
addit
associ
partner
share
interest
dissemin
virus
reagent
beneficiari
eu
grant
includ
see
tabl
associ
formal
signatur
memorandum
understand
archiv
found
principl
member
associ
member
consortium
retain
ownership
virus
dissemin
via
centralis
distribut
centr
virologist
institut
suppli
virus
custom
retain
ownership
enter
agreement
custom
via
materi
transfer
agreement
mta
order
virus
associ
reagent
cell
cultur
recombin
protein
rna
dna
recombin
virus
plasmid
monoclon
antibodi
place
via
websit
http
www
europeanvirusarchivecomwhich
manag
central
marseil
manag
team
partner
aixmarseil
univers
earli
stage
exist
origin
eva
emphasi
place
establish
collect
virus
associ
reagent
ensur
qualiti
control
manag
central
ensur
laboratori
compli
ident
standard
principl
develop
project
manag
appoint
head
manag
qualiti
committe
respons
establish
maintain
appropri
standard
close
monitor
procedur
protocol
record
mainten
ensur
uniform
throughout
consortium
qualiti
manag
repres
partner
form
bodi
committe
previous
noneu
particip
given
statu
associ
partner
ie
associ
consortium
full
member
object
evalu
feasibl
approach
concern
collabor
exchang
relat
develop
common
infrastructur
oper
effect
resourc
distribut
point
view
scientif
collabor
process
establish
rapidli
function
effici
howev
standardis
procedur
distribut
materi
endus
prove
challeng
still
develop
improv
within
current
consortium
reason
slow
progress
almost
entir
due
complex
nation
regul
whilst
european
regul
retain
principl
nation
enforc
primarili
control
circul
pathogen
develop
maintain
uniform
throughout
eu
countri
thu
administr
pathway
obtain
authoris
exchang
resourc
exampl
franc
germani
netherland
itali
similar
princip
base
agreement
provid
nation
biosafeti
agenc
contrast
process
exchang
resourc
eu
russia
eu
usa
involv
mani
constraint
intervent
differ
administr
process
authoris
deliveri
hazard
good
includ
biosafeti
agenc
custom
administr
commerc
trade
administr
ministri
health
etc
also
law
russia
permit
import
export
pathogen
nevertheless
expertis
overcom
hurdl
exemplifi
report
studi
viru
crimeancongo
haemorrhag
fever
viru
viru
suppli
european
partner
endus
usa
haddock
et
al
surprisingli
zika
viru
emerg
south
america
found
respons
microcephali
receiv
numer
request
zika
viru
mani
paper
publish
recognit
evag
sourc
viru
five
exampl
encompass
simultan
transmiss
chikungunya
viru
ii
diagnosi
iii
signal
process
pathway
iv
pathogenesi
relat
foetal
infect
v
viru
structur
cite
goertz
et
al
chan
et
al
zhang
et
al
miner
et
al
sirohi
et
al
anticip
problem
transport
pathogen
virus
countri
particularli
outsid
europ
consid
prepar
project
potenti
barrier
effici
exchang
differ
countri
extens
discuss
product
dissemin
object
noneu
partner
defin
depend
specif
statu
establish
oper
satisfactorili
manag
team
continu
process
contact
highcalibr
laboratori
outsid
europ
organis
meet
confer
laboratori
subsequ
invit
becom
associ
partner
current
associ
partnership
negoti
agre
laboratori
africa
russia
china
turkey
australia
japan
germani
itali
hungari
south
korea
south
east
asia
south
america
tabl
initi
earli
progress
evag
alreadi
tremend
achiev
subject
continu
success
expans
anticip
becom
largest
global
network
laboratori
contribut
share
resourc
promot
advanc
virolog
current
agre
associ
partner
evag
integr
institut
share
interest
research
provis
high
qualiti
product
scientif
commun
made
associ
formal
signatur
memorandum
understand
choic
associ
partner
establish
fill
gap
extend
list
virus
current
offer
catalogu
evag
present
geograph
area
concern
emerg
viru
outbreak
dissemin
resourc
includ
knowhow
materi
scientif
commun
one
major
deliver
project
address
creation
webbas
catalogu
access
evag
portal
qualiti
offer
key
factor
differenti
evag
infrastructur
propos
similar
product
endus
gold
standard
product
list
catalogu
clearli
origin
fast
grow
dissemin
activ
consortium
robust
reput
reliabl
provid
key
compon
detect
emerg
virus
act
umbrella
intern
health
organis
evag
infrastructur
provid
widerang
effici
access
viru
collect
held
laboratori
worldwid
potenti
access
recent
isol
virus
clinic
veterinari
field
sampl
collect
continu
expand
number
contribut
laboratori
increas
provid
particip
access
materi
capac
includ
freezedri
virus
longterm
storag
virus
valid
sequenc
includ
rescu
characteris
archiv
materi
reagent
kit
includ
primer
sequenc
appropri
protocol
viru
identif
standardis
diagnost
kit
recombin
protein
repres
gene
virus
hyperimmun
antisera
defin
specif
customprepar
kit
protein
antibodi
highqual
associ
research
laboratori
access
perform
experi
theoret
practic
train
relev
inform
obtain
place
enquiri
websit
wwweuropeanvirusarchivecomevagport
time
write
catalogu
show
product
consist
virus
associ
reagent
list
constantli
increas
includ
human
anim
insect
fish
plant
virus
medic
veterinari
academ
industri
econom
import
addit
rang
arthropod
tissu
cultur
cell
line
monoclon
antibodi
recombin
protein
express
system
purifi
viral
rna
specialis
kit
diagnosi
customprepar
protein
also
obtain
websit
approach
qualiti
manag
direct
project
qualiti
standard
base
upon
organ
econom
cooper
develop
oecd
guidelin
critic
focuss
acquisit
characteris
storag
viru
product
partner
institut
seek
compli
way
work
harmonis
laboratori
process
across
consortium
qualiti
manag
conduct
best
practic
audit
quantifi
improv
progress
facil
inspect
regul
nation
bio
safeti
author
employ
staff
train
procedur
compliant
requir
intern
air
transport
associ
iata
safe
dispatch
potenti
hazard
materi
transnat
access
tna
ensur
free
charg
access
european
research
infrastructur
cost
research
product
associ
activ
opportun
open
european
research
extent
research
noneu
countri
tna
dispatch
includ
regulatori
document
importexport
permit
certif
analysi
coa
provid
suppli
partner
evag
project
establish
grade
system
defin
viru
product
qualiti
rank
grade
basic
level
describ
partial
sequenc
confirm
ident
check
mycoplasma
contamin
unknown
infect
store
frozen
gold
standard
fulli
sequenc
viru
mycoplasmafre
defin
infect
lyophilis
longterm
storag
deriv
product
protein
nucleic
acid
antigen
also
prepar
use
standardis
protocol
check
qualiti
storag
dispatch
secur
consortium
institut
maintain
use
cctv
pincod
pass
remot
site
man
securityvehicl
identif
entri
bio
contain
laboratori
strictli
control
suppli
product
applic
oper
via
tna
approach
defin
wherebi
research
group
appli
web
portal
submiss
complet
request
form
success
applic
must
justifi
explan
scientif
object
techniqu
utiliseddevelop
list
name
research
list
relev
public
confirm
appropri
expertis
facil
handl
viru
place
review
criteria
carri
project
qualiti
manag
select
panel
includ
extern
expert
team
scientist
administr
dedic
manag
evag
ensur
continu
maxim
effici
whilst
individu
laboratori
oper
webbas
catalogu
suppli
endus
virus
product
held
collect
websit
main
commun
tool
inform
endus
dissemin
product
dedic
portal
portal
conceiv
userfriendli
marketplac
list
virus
associ
reagent
partner
webbas
catalogu
constitut
singl
entri
point
archiv
virus
reagent
provid
access
endus
place
enquiri
product
interest
commonli
use
eshop
format
endus
could
entitl
free
access
viru
associ
reagent
provid
request
item
receiv
financi
compens
eu
budget
eu
support
freeofcharg
access
provid
endus
main
object
facilit
access
scientif
commun
high
qualiti
resourc
howev
condit
excel
project
endus
aim
develop
use
resourc
intern
panel
consist
independ
expert
review
request
free
access
subject
approv
custom
receiv
item
without
charg
cover
cost
transport
case
charg
requir
suppli
viru
reagent
evag
recov
cost
product
transport
custom
freeofcharg
access
endus
employ
outsid
eumemb
euassoci
state
limit
total
access
provid
grant
addit
core
partner
project
also
integr
associ
partner
effici
mean
enlarg
collect
virus
reagent
webcatalogu
easi
effici
access
virus
reagent
servic
offer
scientif
commun
attract
increas
number
request
product
catalogu
addit
qualiti
product
distribut
assist
provid
manag
team
answer
specif
question
scientist
establish
evag
key
biolog
resourc
centr
worldwid
recognis
entiti
act
umbrella
medic
veterinarian
intern
health
organis
includ
goarn
oie
major
centr
diseas
control
prevent
around
world
underpin
control
emerg
viral
diseas
place
enquiri
receiv
quotat
product
open
web
browser
type
evag
click
loginregist
creat
account
onlin
catalogu
access
via
portal
link
home
page
product
catalogu
found
type
keywordandor
appropri
taxonom
name
filter
right
hand
side
portal
also
use
brows
product
categori
product
interest
simpli
ad
enquiri
cart
enquiri
form
complet
materi
transfer
agreement
mta
quotat
product
ship
cost
sent
endus
enquiri
becom
order
quot
accept
mta
sign
enquiri
evalu
term
biosafeti
offici
sign
stamp
endus
qualif
form
laboratori
receiv
handl
product
interest
request
emerg
sar
end
clearli
demonstr
lack
prepared
countri
face
emerg
viru
outbreak
concept
eva
discuss
aspect
consortium
activ
clearli
state
project
submit
european
commiss
reinforc
second
project
evag
submit
conting
fund
dedic
support
activ
emerg
novel
merscov
human
saudi
arabia
provid
opportun
consortium
partner
member
european
epidem
respons
network
develop
precis
rapid
mer
cov
diagnost
tool
suitabl
field
diagnosi
emerg
condit
corman
et
al
decemb
recommend
pcr
assay
method
detect
viru
blood
sampl
identifi
evag
reliabl
sourc
deliveri
posit
control
reagent
date
kit
distribut
worldwid
laboratori
countri
achiev
demonstr
capac
consortium
mobil
highcalibr
scientist
capabl
rapidli
develop
suppli
technic
solut
highlevel
emerg
situat
involv
human
pathogen
agent
anoth
key
featur
achiev
effici
logist
platform
distribut
materi
worldwid
demand
condit
prevail
time
zika
viru
emerg
french
polynesia
spread
rapidli
south
america
caribbean
caus
least
clinic
case
within
first
year
accord
pahowho
estim
februari
declar
public
health
emerg
intern
concern
pheic
see
ref
februari
us
centr
diseas
control
uscdc
elev
respons
level
activ
ie
highest
level
prior
may
two
strain
zika
viru
evag
onlin
catalogu
first
trimest
peak
intern
concern
partner
ad
eight
product
direct
relev
emerg
situat
sinc
novemb
evag
receiv
enquiri
product
distribut
countri
total
product
provid
februari
alon
highest
demand
usa
singapor
netherland
germani
franc
china
interim
guidanc
zika
viru
laboratori
test
march
identifi
evag
provid
pcr
qualitycontrol
materi
corman
et
al
emerg
situat
result
need
coordin
distribut
logist
challeng
consequ
manag
team
introduc
procedur
allevi
burden
partner
improv
product
access
achiev
establish
addit
distribut
hub
zika
viru
product
obtain
centr
molecular
diagnost
therapi
crie
moscow
russia
wuhan
institut
virolog
wiv
wuhan
southern
china
nation
institut
infecti
diseas
niid
tokyo
japan
manag
team
also
negoti
common
materi
transfer
agreement
mta
industri
behalf
consortium
member
centralis
exchang
logist
platform
establish
experi
underlin
realiti
anticip
prepared
key
compon
effect
respons
public
health
emerg
decemb
may
brazil
report
largest
yellow
fever
yf
outbreak
decad
total
suspect
case
death
fischer
et
al
prompt
widespread
yellow
fever
viru
yfv
vaccin
campaign
need
distinguish
vaccineand
wildtyp
yfvassoci
diseas
novel
multiplex
realtim
revers
transcript
pcr
differenti
vaccin
american
wildtyp
yfv
develop
consortium
partner
respons
outbreak
valid
field
condit
fischer
et
al
centr
diseas
control
cdc
countri
play
import
role
control
viru
outbreak
collect
data
sampl
identif
phase
pathogen
howev
academ
research
combin
materi
collect
appear
unavoid
actor
prepared
control
emerg
viru
diseas
time
variant
form
new
form
pathogen
respons
combin
organ
cdc
high
calibr
research
laboratori
foreseen
best
solut
reach
effici
control
viru
propag
prepared
next
outbreak
time
cover
rang
pathogen
made
possibl
constitut
group
high
contain
facil
within
organ
sixteen
regist
biosafeti
laboratori
resourc
handl
highest
risk
pathogen
five
cdc
partner
associ
partner
consortium
cdc
contribut
directli
manag
control
emerg
viru
diseas
umbrella
evag
also
associ
global
outbreak
alert
respons
network
goarn
recognis
goarn
supplier
high
qualiti
virus
virusrel
reagent
resourc
ebola
viru
epidem
west
africa
institut
directli
involv
help
local
author
contain
epidem
gain
import
experi
manag
health
crise
collect
field
sampl
isol
relev
viru
strain
mani
characteris
store
facil
evag
partner
bernard
nocht
institut
hamburg
germani
addit
address
specif
issu
involv
manag
exchang
high
risk
pathogen
activ
platform
dedic
offer
servic
appropri
endus
consortium
third
year
exist
framework
programm
ultim
object
becom
perman
archiv
provid
access
wide
rang
virus
reagent
global
achiev
firstli
extens
fund
arrang
secondli
increas
rang
contributor
collect
thirdli
bridg
larg
european
intern
infrastructur
activ
relat
evag
includ
would
naiv
suggest
longterm
surviv
consortium
straightforward
exampl
perpetu
requir
continu
increasingli
larg
fund
stream
meet
almost
restrict
cost
research
laboratori
develop
upkeep
face
newli
emerg
highli
pathogen
virus
sustain
key
issu
infrastructur
consortium
plan
remain
nonprofit
organ
obviou
consequ
fundament
choic
access
diversifi
sourc
fund
nation
partner
belong
support
collect
activ
includ
infrastructur
manag
well
research
concern
develop
new
tool
necessari
keep
archiv
process
date
financi
support
action
involv
prepared
emerg
viral
diseas
eg
distribut
bioresourc
suppli
reagent
detect
infect
patient
local
level
come
govern
health
depart
intern
level
european
commiss
charit
intern
health
fund
agenc
wellcom
trust
foundat
bill
melinda
gate
foundat
oie
futur
financi
plan
also
includ
creation
specif
interfac
industri
sector
consortium
first
instanc
interfac
explor
bidirect
opportun
organ
scientif
exchang
prioriti
access
bioresourc
includ
refer
materi
develop
diagnost
servic
valid
diagnost
assay
commerci
industri
partner
benefit
parti
sign
contract
collabor
facilit
procedur
harmon
note
concept
evag
uniqu
far
awar
equival
viral
archiv
collect
provid
access
reagent
backup
sequenc
data
proven
qualiti
control
capac
advertis
inform
negoti
conduct
entir
transact
endus
via
web
intern
regist
secur
transport
compani
reput
high
qualiti
experi
knowledg
consortium
partner
combin
integr
european
commiss
infrastructur
provid
endus
opportun
approach
new
field
research
structur
viral
genom
evolutionari
biolog
control
infecti
diseas
antivir
drug
design
fundament
research
public
environment
health
pathogenesi
immunolog
wide
varieti
associ
disciplin
subsequ
subject
continu
fund
appropri
justif
evag
aim
extend
divers
disciplin
encompass
fish
plant
bacteri
fungal
protist
current
unrecognis
virus
achiev
first
expans
within
european
commun
follow
integr
specialist
laboratori
america
russia
asia
southeast
asia
australia
africa
recent
creat
african
cdc
provid
uniqu
opportun
establish
strong
link
public
health
institut
africa
substanc
relationship
base
trust
mutual
benefit
instanc
train
workshop
staff
exchang
organ
object
develop
appropri
infrastructur
directli
integr
evag
format
level
scientif
expertis
qualiti
rang
product
justifi
integr
evag
full
partner
within
consortium
evag
provid
rang
virus
relev
reagent
endus
engag
wide
varieti
establish
infrastructur
instanc
newli
creat
eu
infrastructur
infravec
european
infrastructur
insect
diseas
vector
research
control
http
suppli
infecti
vector
eg
mosquito
tick
endus
evag
close
associ
activ
via
provis
virus
infect
vector
erinha
http
www
erinhaeu
european
strategi
forum
research
infrastructur
esfri
wwwesfrieu
offer
access
high
contain
facil
industri
endus
preclin
trial
includ
pathogen
recommend
evag
provid
virus
necessari
trial
bbmri
anoth
esfri
plan
creat
servic
unit
dedic
provis
virus
deriv
materi
virus
evag
identifi
recommend
supplier
evag
contribut
function
eu
infrastructur
involv
relat
research
topic
includ
zoonot
diseas
drug
discoveri
vaccin
develop
viral
epidemiolog
emerg
viru
diseas
eufund
project
includ
prepar
platform
european
prepared
emerg
epidem
http
cordi
compar
collabor
manag
platform
detect
analys
emerg
foodborn
outbreak
europ
http
wwwcompareeuropeeuabout
emerg
effici
respons
highli
danger
emerg
pathogen
eu
level
http
wwwemergerkieu
zikalli
multin
multidisciplinari
research
consortium
coordin
insermhttp
zikalliancetghnorgabout
futur
object
one
imagin
gener
link
among
organis
constitut
life
scienc
infrastructur
cooper
dedic
virologyrel
topic
evag
could
play
central
role
longterm
futur
plan
establish
closer
collabor
link
compat
scientif
infrastructur
initi
teach
train
programm
amongst
younger
scientist
ensur
peopl
right
calibr
abl
undertak
role
current
occupi
experienc
matur
scientist
inde
one
could
envisag
elearn
programm
built
diploma
cours
univers
continu
ambiti
mission
build
scientif
infrastructur
benefit
scientist
oper
area
viral
world
recognis
agenc
research
team
provid
valuabl
dataset
analyt
expertis
diseas
intervent
strategi
might
develop
inde
compat
agenc
approach
consortium
share
resourc
promot
activ
consortium
websit
yet
anoth
avenu
explor
base
complementar
parti
exist
group
partner
time
write
wit
massiv
impact
nextgener
sequenc
technolog
undoubtedli
continu
evolv
provid
even
discoveri
one
might
exploit
futur
larger
comprehens
form
agenc
sinc
first
recognit
virus
obsess
tri
understand
control
excit
time
virologist
long
may
evag
successor
ensur
alway
case
public
support
european
viru
archiv
global
evag
project
receiv
fund
european
union
horizon
research
innov
programm
grant
agreement
